Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Neuroblastoma × Lenalidomide × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Unknown 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 17 Lymphoma, Large B-Cell, Diffuse 16 Recurrence 6 Neoplasms, Plasma Cell 4 Leukemia, Myeloid, Acute 4 Myelodysplastic Syndromes 3 Lymphoma, T-Cell, Peripheral 3 Lymphoma, Mantle-Cell 3 Lymphoma, B-Cell 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Neoplasms by Histologic Type 2 Lymphoma, Non-Hodgkin 2 Lymphoma, B-Cell, Marginal Zone 2 Lymphoma 2 Leukemia, Myelomonocytic, Chronic 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Hodgkin Disease 2 Colorectal Neoplasms 2 Renal Insufficiency 1 Paraproteinemias 1 Neuroblastoma 1 Neoplasms 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Follicular 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Accelerated Phase 1 Leukemia, Biphenotypic, Acute 1 Intraocular Lymphoma 1 Immunoglobulin Light-chain Amyloidosis 1 Hematologic Diseases 1

Interventions

Cyclophosphamide 9 Vincristine 7 Radiotherapy 7 Carboplatin 7 Etoposide 6 Cisplatin 6 3-Iodobenzylguanidine 6 Melphalan 5 Doxorubicin 5 Isotretinoin 4 Filgrastim 4 aldesleukin 3 Peripheral Blood Stem Cell Transplantation 3 Neoadjuvant Therapy 3 Busulfan 3 fludarabine 2 etoposide phosphate 2 Vorinostat 2 Topotecan 2 Polymerase Chain Reaction 2 Interleukin-2 2 Ifosfamide 2 Chemotherapy, Adjuvant 2 irinotecan sucrosofate 1 ganglioside, GD2 1 fludarabine phosphate 1 endostar protein 1 dinutuximab 1 Watchful Waiting 1 Vinorelbine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04049864 2022-03-02

DNA Vaccination Against Neuroblastoma

Belarusian Research Center for Pediatric Oncology, Hematology and Immunology

Phase EARLY_PHASE1 Unknown

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡